                         SEQUENCE LISTING

<110>  Fred Hutchinson Cancer Research Center
 
<120>  COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION

<130>  F053-0135PCT / 21-007-WO-PCT

<150>  US 63/109,271
<151>  2020-11-03

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Rac1 Inhibitor W56

<400>  1

Met Val Asp Gly Lys Pro Val Asn Leu Gly Leu Trp Asp Thr Ala Gly 
1               5                   10                  15      


<210>  2
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miR29c

<400>  2
uagcaccauu ugaaaucggu ua                                                22


<210>  3
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miR29c

<400>  3
ugaccgauuu cuccuggugu uc                                                22


<210>  4
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miR29c

<400>  4
uagcaccauu ugaaaucggu                                                   20


<210>  5
<211>  88
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  mmu-miR-29c-5p (miR29c inhibitor)

<400>  5
aucucuuaca caggcugacc gauuucuccu gguguucaga gucuguuuuu gucuagcacc       60

auuugaaauc gguuaugaug uaggggga                                          88


<210>  6
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  b-actin forward primer

<400>  6
cactgtcgag tcgcgtcc                                                     18


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  b-actin reverse primer

<400>  7
tcatccatgg cgaactggtg                                                   20


